These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 8904244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J, Alvarez de Arcaya Vicente A, Arbeo Escolar AM, Peña Soria MJ, Alvarez Fernández-Represa J.
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cystic fibrosis lung disease and its management].
    Hidaka N, Hidaka Y.
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functions of the cystic fibrosis transmembrane conductance regulator protein.
    Frizzell RA.
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S54-8. PubMed ID: 7533606
    [Abstract] [Full Text] [Related]

  • 13. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E, Jablonsky M, Naren AP, Jackson PL, Muccio DD, Kirk KL.
    Proc Natl Acad Sci U S A; 2004 May 25; 101(21):8221-6. PubMed ID: 15141088
    [Abstract] [Full Text] [Related]

  • 14. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L, Chávez M, Saldaña Y, Velázquez R, Carnevale A, González-del Angel A, Jiménez S.
    Rev Invest Clin; 2006 May 25; 58(2):139-52. PubMed ID: 16827266
    [Abstract] [Full Text] [Related]

  • 15. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.
    Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ.
    Nature; 1993 Mar 11; 362(6416):160-4. PubMed ID: 7680769
    [Abstract] [Full Text] [Related]

  • 16. [The cystic fibrosis gene, its product CFTR protein and its mutations].
    Goossens M, Fanen P, Costes B, Ghanem N.
    Bull Acad Natl Med; 1993 Mar 11; 177(3):371-80; discussion 380-1. PubMed ID: 7689915
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.
    Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, Jefferson DM, McCann JD, Klinger KW, Smith AE, Welsh MJ.
    Nature; 1990 Sep 27; 347(6291):358-63. PubMed ID: 1699126
    [Abstract] [Full Text] [Related]

  • 20. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M.
    Nature; 1990 Sep 27; 354(6354):526-8. PubMed ID: 1722027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.